Tomoe Shimazaki

878 citations
21 papers · 449 indexed · h-index 10
Topics
Hepatitis C virus research (11 papers)Liver Disease Diagnosis and Treatment (5 papers)Hepatitis B Virus Studies (4 papers)

In The Last Decade

Tomoe Shimazaki

21 papers receiving 445 citations

Peers

Tomoe Shimazaki
Comparison fields: 5 of 56
  • Hepatology 220
  • Epidemiology 170
  • Oncology 97
  • Molecular Biology 95
  • Physiology 73
Replace Richard S. Hann with:
Richard S. Hann United States
Ahmed Eid Israel
Hiroshige Kojima Japan
Hong-Di Ma China
Volker Meier Germany
Wafaa M. Ezzat Egypt
Nick Shackel Australia
Kazuya Okushin Japan
Pengfei Huang China
Tomoe Shimazaki relative to Richard S. Hann United States Richard S. Hann's profile →
Citations per field
00.5×12×
Richard S. Hann · 1×
Citations per year

Countries citing papers authored by Tomoe Shimazaki

Since Specialization
Citations

This map shows the geographic impact of Tomoe Shimazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomoe Shimazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomoe Shimazaki more than expected).

Fields of papers citing papers by Tomoe Shimazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomoe Shimazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomoe Shimazaki. The network helps show where Tomoe Shimazaki may publish in the future.

Co-authorship network of co-authors of Tomoe Shimazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tomoe Shimazaki. A scholar is included among the top collaborators of Tomoe Shimazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomoe Shimazaki. Tomoe Shimazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 20
2 16
3 23
4 9
5 4
6 6
7 24
8 4
9 4
10 5
11 20
12 17
13 9
14 5
15 110
16 35
17 5
18 58
19
[Combination chemotherapy of adult T-cell leukemia (ATL) using cyclophosphamide, vindesine and prednisolone (CV'P)].
3
20
[Clinical significance of serum beta 2-microglobulin as a tumor marker of oral and maxillofacial malignant tumors].
2

About Tomoe Shimazaki

Tomoe Shimazaki is a scholar working on Hepatology, Infectious Diseases and Rheumatology, having authored 21 papers that have together received 449 indexed citations. Recurring topics across this work include Hepatitis C virus research (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Hepatitis B Virus Studies (4 papers). The work is most often cited by research in Hepatology (220 citations), Epidemiology (170 citations) and Oncology (97 citations). Tomoe Shimazaki has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kenichi Morikawa, Takuya Matsumura, Naoya Sakamoto, Michio Imawari, Takayoshi Ito, Kazumasa Hiroishi, Takuya Sho, Mitsuteru Natsuizaka, Osamu Maehara and Koji Ogawa. Their work appears in journals such as Nature Communications, SHILAP Revista de lepidopterología and Mutation research. Fundamental and molecular mechanisms of mutagenesis.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026